William Sumner, Author at Green Market Report

William SumnerWilliam SumnerMarch 14, 2019
daily_hit004-1280x533.png

4min2110

It’s time for your Daily Hit of cannabis financial news for March 14, 2019.

On the Site

HEXO Corp.

HEXO Corp (TSX: HEXONYSE: HEXO) delivered its financial results for the second quarter of the 2019 fiscal year with gross revenue of $16.2 million an increase of 1,269% versus the same time period for last year. Revenues increased by 114% sequentially.The company reported a net loss for the quarter of $4.3 million, which was a big improvement over last year’s net loss of $8.9 million for the same time period.

Green Peak Innovations LLC.

Michigan-based cannabis ag-tech company Green Peak Innovations LLC closed on a $30+ million capital raise in an oversubscribed mezzanine debt round. The company plans to use the money for expansion purposes within its home state. Green Peak Innovations is fully licensed by the LARA Bureau of Medical Marijuana Regulation as the largest holder of “Class C” cultivation licenses, processing, and has plans in place to open 19 provisioning centers

In Other News

Aleafia Health Inc.

Aleafia Health Inc. (TSXV: ALEF) announced that is has closed its acquisition of Emblem Corp. (TSXV: EMC). Under the arrangement, Aleafia has acquired all of Emblem’s common shares and will combine the company with Aleafia’s wholly-owned subsidiary 11208578 Canada Inc., continuing as Emblem Corp. “The acquisition of Emblem rapidly accelerates the execution of Aleafia Health’s strategy and positioning as a vertically integrated, diversified cannabis company with an integrated, highly differentiated consumer ecosystem,” said Aleafia CEO Geoffrey Benic in a statement.

Tilray Inc.

Tilray Inc. (NASDAQ: TLRY) has finalized its CBD supply agreement with LiveWell Canada Inc. (CSE: LVWL). Under the agreement, LiveWell will supply Tilray with up to 150 kilograms of hemp-derived CBD isolate or full-spectrum CBD extract at equivalent amounts. That amount will increase to 300 kilograms as of August 2019, with an option to increase to 500 kilograms per month. The agreement will remain remain in effect until January 31, 2020; upon which it will automatically renew for another year unless either party decides to end the agreement. “We’re thrilled to have the opportunity to partner with Tilray, one of the best known and most stringent companies in the cannabis and cannabinoid space,” said David Rendimonti, President and CEO of LiveWell Canada, in a statement.


William SumnerWilliam SumnerMarch 11, 2019
PuertoRico.jpg

3min1740

SLANG Worldwide Inc. (CNSX: SLNG) is heading to Puerto Rico. Yesterday, the company announced that it has entered into a strategic partnership with Southern Development Holdings (SDH) to sell its branded products to medical cannabis patients in Puerto Rico. As part of the partnership, SDH has been granted an exclusive license to sell SLANG branded products in the province.

“We are excited to bring our high-quality brands to consumers in Puerto Rico and the Latin American market,” said SLANG CEO Peter Miller.  “Building global brands requires teamwork. Leveraging partnerships with the highest calibre operators enhances SLANG’s brand share and revenue with impressive scalability.”

Medical cannabis was first legalized in Puerto Rico in 2015 when then-Governor Alejandro Garcia Padilla legalized the substance through executive order. The province recognizes 14 qualifying conditions for medical cannabis; including multiple sclerosis, cancer, and depression.

The market took a major hit in 2017 when Hurricane Maria destroyed much of the island’s infrastructure, but after more than a recovery, some semblance of normalcy has returned.

Although typically not thought of as a major medical cannabis market, Puerto Rico has one of the highest rates of patients per capita in the United States. Out of the province’s 3.3 million population, roughly 59,000 individuals are patients; the majority of which, according to Marijuana Business Daily, are over the age of 55.

Puerto Rico also offers reciprocal access to its 71 dispensaries for visiting patients from other medical cannabis states.

SLANG’s entry into the Puerto Rican market represents the company’s second market expansion this year. Last month, SLANG announced that they would partner with the medical cannabis chain Trulieve Cannabis to offer its products to patients in the state of Florida. SLANG products are now available in 11 U.S. states and 2,600 retail locations.

Under the agreement, SDH will manufacture SLANG products in its GMP certified manufacturing facility. Sales of SLANG products in Puerto Rico are expected to begin in the second quarter of 2019.


William SumnerWilliam SumnerFebruary 22, 2019
stocks.jpg

3min4340

The cannabis industry continues to catch the attention of institutional investors in the United States. Earlier this week, Seaport Global, released a lengthy report analyzing the global cannabis market and initiating coverage on over a dozen of the industry’s leading cannabis firms.

With offices in both New Orleans and New York, Seaport Global is a full-service investment bank that offers capital markets advisory and research services.

“We are formally launching coverage of the global cannabis space. This exciting market area is evolving quickly, with hundreds of public companies coming to market in recent years. There is clear momentum behind the legalization of cannabis, around the world. We expect many countries, including the US, to go legal within the next handful of years, and we think that this will create a considerable forward opportunity for the burgeoning industry that is regulated, legal cannabis,” reads the report.  “From a little over $12B in global value today, we see the market ultimately evolving to almost $630B in due time.”

Looking forward, the report projects that the cannabis market will diverge into two distinct markets, a retail dispensary model centered around the adult use market and a medicinal model offered through traditional channels.

Seaport is initiating coverage on Canopy Growth Corp. (NYSE: CGC), Tilray (NASDAQ: TLRY), and Aurora Cannabis (TSX: ACB) with a neutral rating. Curaleaf Holdings (CSE: CURA), Green Thumb Industries (OTC: GTBIF), iAnthus Capital (OTC: ITHUF), KushCo Holdings (OTC: KSHB), and MedMen Enterprises (OTCL MMNFF) were given Buy ratings. Seaport’s top picks were Hexo Corp. (NYSE: HEXO), Aphria Inc. (NYSE: APHA), Acreage Holdings (OTC: ACRGF), and Green Organic Dutchman (OTC: TGODF).

In addition to initiating coverage on the leading cannabis companies, the report also provides an in-depth analysis of the global cannabis market; including market size, legal status, a supply chain diagnostic, regulatory information, projected market size for 106 countries, and an examination of the market dynamics between the U.S. and Canadian market.

The report also provides a 50-state profile which includes political and regulatory information, a breakdown between the medical and adult use market, weekly spot margin calculations, an examination of the hemp-CBD market, and a segmented rundown of over 100 public cannabis companies.

The 208-page report is available online to clients of Seaport Global.


William SumnerWilliam SumnerFebruary 12, 2019
apoth2.jpeg

3min6520

Yesterday, the San Francisco-based cannabis dispensary chain, The Apothecarium, announced that they had been acquired by TerrAscend Corp. (CSE: TER) for $118.4 million in cash and stock. Including in the purchase agreement are three retail dispensaries in San Francisco; one vertically integrated cannabis operation which includes cultivation, edibles manufacturing, and a retail dispensary location; and the edibles brand Valhalla Confections.

With more than 200 employees and $45 million in combined revenue, Apothecarium made for an attractive buy to TerrAscend, which recently has been making moves to enter the U.S. market.

Last month, TerrAscend completed the acquisition of another U.S. company Grander Distribution, LLC. Grander is a producer and distributor of hemp-based wellness products that are available in more than 10,000 worldwide retail locations.

“Teaming up with a larger company means that we will be able to bring the Apothecarium dispensary experience to more people, in more cities around the country,” said Apothecarium CEO Ryan Hudson in a statement. “Our customers won’t see major changes inside our dispensaries.”

Under the agreement, TerrAscend has agreed to pay $73.7 million in cash and to grant 7.325 million proportionate voting shares in the company. All full-time employees, including budtenders, will receive shares of TerrAscend.

Additionally, Apothecarium’s CEO and leadership team are expected to remain in their current roles. The completion of this acquisition is still pending regulatory approval from both the states of California and Nevada.

“Today’s news is another major step in executing TerrAscend’s US strategy,” said TerrAscend President Matthew Johnson. “We believe The Apothecarium is the model for operational excellence and will set the tone for our US cultivation and retail expansion, and we admire their philanthropic dedication and local community engagement.  We look forward to working together with the members of the current team to bring the Apothecarium’s unique experience to more communities and improve patient access to quality cannabis products and services.”


William SumnerWilliam SumnerJanuary 4, 2019
shutterstock_513689059-1280x854.jpg

4min2480

In the absence of sensible federal cannabis reform, a growing number of US-based companies are looking to do business in Canada, where adult-use cannabis is fully legal. Aside from the simple issue of legality, cannabis companies operating in Canada are also able to list themselves on publicly traded stock-exchanges, such as the Canadian Securities Exchange (CSE), whereas most US-based companies cannot.

For those cannabis companies hoping to do business north of the border, the question becomes: how does one take their company public in Canada and when is the right time to do it? A new report released by MGO-ELLO Alliance attempts to answer this question.

MGO-ELLO Alliance is a professional collaboration between MGO LLP, a company dedicated to CPA and financial advisory services, and ELLO LLC, which focuses on cannabis financial services. MGO-ELLO Alliance aims to help shepherd emerging companies through the increasingly complex cannabis industry.

“As the cannabis industry continues to experience massive growth, inevitable financial and operational challenges will develop and the MGO-ELLO alliance is uniquely positioned to provide the highest quality consulting and professional services needed,” said ELLO CEO, Evan Eneman, in a statement announcing the partnership.

In the report, MGO-ELLO Alliance weighs the pros and cons of going public. For example, one of the advantages of going public is that it is easier to raise capital and attract top talent. The tradeoff, however, is that publicly traded companies, especially those in the cannabis space, are under increased scrutiny and are subject to strict regulatory oversight.

The report also covers the differences between going public through an initial public offering (IPO) and a reverse takeover (RTO). Generally seen as the traditional way of going public, IPOs involve filing a preliminary prospectus form with securities regulators and allow companies to raise as much money as possible.

RTOs, which is where a company goes public by buying a publicly traded company, represents a growing trend among cannabis companies in the United States.  The reason why is that RTOs are quicker, cheaper, and subject to less oversight than traditional IPOs. The tradeoff, however, is that the purchasing company will have to issue a percentage of its shares to legacy shareholders of the purchased company. There also may be hidden liabilities that the purchasing company may have to deal with.

For US-based companies hoping to do business in Canada, the MGO-ELLO Alliance report provides a detailed walkthrough of how to go public through both an IPO and RTO, as well what the regulatory expectations are for publicly traded companies.

To view the full report, click the following link or visit the report section on Green Market Report.


William SumnerWilliam SumnerJanuary 2, 2019
money2-2.jpg

3min2670

Cannex Capital Holdings Inc. (CSE: CNNX) today announced its financial results for the second quarter of the 2019 fiscal year, which ended on October 31, 2018.

Revenue for the quarter rose to $3.05 million, up roughly 223% from $1.8 million during the same period in the previous year. The bulk of the revenue increase was attributed packaging sales and rental income.

Likewise, the company’s net income rose to $696,746; a significant increase when compared to the loss of $815,188 during the second fiscal quarter of 2018. Adjusted EBITDA decreased slightly, falling from $1.1 million to $1.03 million. At the end of the period, Cannex had approximately $10.04 million in cash and cash equivalents.

Following the end of the quarter, Cannex took several steps to strengthen its balance sheet; including signing a binding letter of agreement to merge with 4Front Holdings LLC. In an all-stock transaction. The merger is still pending due diligence regulatory approval, and there is no guarantee that merger will be completed as initially proposed.

If completed, the Cannex will own, operate or manage cultivation and production facilities in Washington, Illinois and Massachusetts and five retail operations in Illinois, Massachusetts, Maryland, and Pennsylvania.

The company also secured $32 million in funding from Gotham Green Partners, LLC, and will use the proceeds to retire existing debt and to support Cannaex’s multi-state operations.

“Cannex is pleased with another quarter of good topline results driven by continuing strong performance of our Washington State operations,” said Anthony Dutton, CEO of Cannex. “Washington is a critical component to our long-term strategy and forms the underpinnings of our operational template that we will leverage as Cannex expands into additional jurisdictions as a part of our recently announced business combination with 4Front Holdings.”

It has been a rough year for Cannex’s stock, despite the recent gains over the last quarter. Since March 2018, the company’s share price has been on a slow decline, bottoming out at around CAD$0.56 in late October. Since then, however, Cannex has been on the rise and is currently trading at or around CAD$0.96.


William SumnerWilliam SumnerDecember 21, 2018
emerald3.jpg

6min5470

Amidst the glitz and the glamor of the growing cannabis industry, it can be easy to lose touch with the industry’s communal roots. Before billion-dollar companies and institutional investors swooped in to infuse the industry with cash and an air of legitimacy, outlaw growers and sellers gathered together to swap stories and honor one another for excellence in the then-illegal art of growing cannabis; and it is in this spirit that the first Emerald Cup was born.

Taking place in Santa Rosa, California, the fifteenth annual Emerald Cup is a far cry from the original. Where once the Emerald Cup, also known as the Academy Awards of Cannabis, was just a small gathering of cannabis cultivators and enthusiasts, the event now attracts national media outlets and world-famous celebrities like Willie Nelson and Kevin Smith.

Throughout the course of the two-event, the Emerald Cup saw approximately 27,000 attendees and over 250 vendors. In stark contrast to other investor-focused cannabis conferences, where cannabis-use is often banned, dozens of booths and tents were erected to allow attendees to talk with judges and partake in many of the cannabis brands on display at the event.

This year’s event also had the distinction of being the first Emerald Cup to take place since adult-use cannabis sales became legal in the state of California. Although many welcomed California’s first year of adult-use sales, it was also a year where many cannabis companies in the state where forced to close their doors; due primarily to shifting regulations on both a state and local level.

Consequently, many of the cannabis brands that entered the Emerald Cup already felt like winners, if only for the fact that they survived a tumultuous year in California cannabis. Other cannabis brands, like The Original Jack Herer, found the event’s timing particularly poignant.

Named after the late cannabis activist, Jack Here, The Original Jack Herer took home the Emerald Cup price for best cannabis distillate.

“It’s poetic that Jack wins this year, the first that cannabis is legalized for adults statewide,” said Jack Herer brand writer Jorie Henrickson.

Accepting the award for the brand was Herer’s son, Dan Herer, who gave a moving acceptance speech.

“Thank you to my partner Latif and our formulator Dustin [Snyder] for working for nearly a year to perfect the product that we put out. And I’m so grateful for all the love and response that we got back,” said Herer.

Here is the full list of 2018 Emerald Cup Winners:

Licensed Sun-Grown
Ridgeline Farms – Green Lantern
Rebel Grown– Double OG Chem #15
Tar Hill – Cherimoya

Licensed Mixed Light
Tar Hill – Pink Lemonade
Josh D. – OG Kush Story
DEVI – Peanut Butter Breath

Personal Sun-Grown
JD Lee – Chili Verde
Paula Hudgins – Wedding Cake
Cory Rodgers – Cherry Punch 15

Edibles
Utopia – Raspberry Macarons
SolDaze – Tropical Mango Bites
Budlette Confections – Mellows Black Sesame

Tinctures
Alchemy Jane – Create THC Tincture
OM Edibles – Nighttime Elixer
Humboldt Apothecary – Love Potion No. 7

Topicals
Newell’s Botanicals – Deep Skin Penetrating Roll-on
OM – Lavender Bath Salts
CAD – Mimosa

Distillate
Herer Group – The Original Jack Herer
Gold Drop/Lemon Tree/Blue River – Lemon Tree
Gold Drop/Bon Vivant/Blue River – Blueberry Muffin

CO2
Peak – Huckleberry Zkittlez Amber
WildSeed – Candyland
Big Sur Extracts – Cloud Drop

Diamonds
The Humboldt Cure – The Humboldt Cure Blend Diamonds
WildSeed, LLC – White Recluse Diamonds
NUG – White Buffalo OG Live Resin Diamonds

Live Resin Carts
Fieldz Extracts – Zkittlez Sauce Pen
Friendly Farms – Forbidden Fruit
Fiddler’s Green – Rogue OG Kush

Rosin
GDP Genetics – Super Glue
Fieldz – Zkittles Premium Rosin
Field Extracts – Papaya Premium Rosin

Sauce
Humboldt Terp Council – Zkittlez Cake
Raw Garden – Zookies
Summit Boys – Sundae Driver

Shatter Batter
Suprize Suprize – Cherry Tangerine
Suprize Suprize – Royal Kush BX1 “Badder”
Suprize Suprize – Holy Nana Crack Batter

Solventless
Frosty – Papaya 120u
Tar Hill and Frosty – Tar Hill Pink Lemonade
Papa’s Select, in collaboration with Select Solventless grown by Emerald Queen Farms – GMO 1st Pull 120u Water Hash

CBDs Co2/Distillate
Gold Drop – Lemon Penny

CBD Edibles
Somatik – Goji Berry
OM Edibles – CBD Gummi Melange
Space Gems – VITA Gems

CBD Tinctures
Humboldt Apothecary – Relax
Fiddler’s Green – ACDC Rogue Tincture
Humboldt Harvest – 13:1 CBD Terpene Rich

CBD Topical
Om Edibles – Rose Geranium Bath Salt

CBD Flower
Molecular Farms – Blueberry Banana Bread
Molecular Farms – Dr. Fizz
Molecular Farms – Garlic Jam

CBD Concentrate
Sublime – Sleep
Sublime – High-C


William SumnerWilliam SumnerDecember 12, 2018
daily_hit004-1280x533.png

5min1780

It’s time for your Daily Hit of cannabis financial news for December 12, 2018

On the Site

Aphria Continues International Push With Paraguay Despite Criticism

Aphria Inc.  (TSX: APHA) (NYSE: APHA) continues to forge ahead with its international expansion despite coming under fire from a short seller recently. Recently, Hindenburg Investment Research and Quintessential Capital Management released their short report on the company and questioned some of Aphria’s overseas investments causing the stock to plunge and triggering price target reductions by analysts.

Senate Votes To Pass 2018 Farm Bill, Next Stop Is The House

The 2018 Farm Bill has passed in the U.S. Senate with a vote of 87-13. The legislation goes to the House next for a vote and if it passes there, it will head to the President’s desk to be signed. Hemp will be switched for review to the Department of Agriculture and away from the Justice Department.

LeafLink Says Alaska, Maryland Most Expensive Place To Buy Cannabis

Earlier this week, the cannabis technology platform LeafLink released its 2018 Wholesale Cannabis Pricing Guide and the company learned that Alaska and Maryland are the two most expensive states to buy legal cannabis, followed by Nevada and California.

In Other News

GTEC Holdings Ltd.

GTEC Holdings Ltd. (TSXV: GTEC), a vertically integrated cannabis company, announced today that it had been approved for up-listing of trading onto the OTCQB Venture Market. Effective immediately, the company will start trading on the OTCQB under the symbol GGTTF.

mCig Inc.

mCig Inc. (OTCMKTS: MCIG) announced that Cal Acres Inc., a California company with majority ownership by MCIG, has received its Type-11 Distribution Temporary license from the state of California. Though the company has not completed construction on its distribution facility, Cal Acres may use its license to purchase and store product in a rented facility for the time being. Cal Acres expects that it will receive its cultivation and manufacturing licenses over the next several weeks. “Obtaining a temporary distribution license allows us to interact with the thousands of California Cultivators, Manufacturers, and Distributors… It’s a new launching pad for our future brands,” said Paul Rosenberg, CEO of MCIG Inc.

Mary’s Tech CA

Mary’s Tech CA has announced the opening of a 1,500 square foot manufacturing and distribution facility in Grover Beach, California. The climate-controlled facility utilizes proprietary automation equipment and a high-performance liquid chromatography machine for in-house testing. “We are pleased to officially be operating under our own BCC manufacturing and distribution license and to be in full control of the operations pipeline,” said Lynn Honderd, CEO of Mary’s Tech CA, Inc. “Partnering with EVIO Labs, a premier provider of analytical testing and research, as well as utilizing a robust distribution team, will result in improved efficiencies across the board. Ensuring that patients and consumers in California have consistent access to clean, reliable and accurately dosed products is the utmost importance to us.”


William SumnerWilliam SumnerDecember 12, 2018
Alaska.jpg

4min10460

Earlier this week, the cannabis technology platform LeafLink released its 2018 Wholesale Cannabis Pricing Guide and the company learned that Alaska and Maryland are the two most expensive states to buy legal cannabis, followed by Nevada and California.

Examining the wholesale landscape of some of the most mature cannabis markets in the United States, the guide looks at the average wholesale price of cannabis in eight states: Alaska, Arizona, California, Colorado, Maryland, Nevada, Oregon, and Washington. The product types covered by the report include concentrates, cartridges, edibles, flower, and pre-rolls.

Although the report does not dive into the specifics of why one state is more expensive than another, the authors speculate that the Alaska and Maryland’s high prices are due to the states having a low number of cannabis cultivators. In the two states where cannabis is cheapest, Washington and Oregon, there is currently a glut of cannabis cultivators; leading to low prices and oversupply.

“As the standard wholesale marketplace for the industry’s leading brands, we are able to provide crucial market information to cannabis retailers and brands, which will help inform their plans for 2019,” said LeafLink Co-Founder and CEO Ryan G. Smith in a statement. “As more states like Massachusetts, Connecticut, Pennsylvania, and Michigan continue to establish wholesale operations, we will be able to provide a larger scope of market activity to further empower the LeafLink community, as well as the industry at large.”

Nationwide, the average price for a pound of cannabis flower is $2,124 per pound, while a gram of pre-rolls costs around $5.66 per gram. The average price for cannabis concentrates costs approximately $26.07 per gram and cartridges are priced at around $39.55 per gram. Edible cannabis products, on average, cost around $0.20 per milligram.

When taken on a state-by-state level, cannabis prices start to vary. With regards to cannabis consumer preferences, the report found that consumers prefer products in the lowest 25% price range. The exception to this was pre-rolls. On average, consumers preferred pre-roll products in the 25%-49.99% price range.

The report also examined the relationship between pricing and discounted sales. On average, approximately 16% of the products sold through LeafLink’s platform have a discounted price. Across all eight states examined, discounted products generated 3% more sales than regularly priced products.

The discount effect is magnified when combined with larger sales campaigns. During the last year, LeafLink ran two sales promotions, one in the month leading up to 4/20 (dubbed 3/20) and one in July called 7/10; which is a considered an industry-wide “holiday” for concentrates.

When combined with those larger sales campaigns, discounted products generated 37% more sales on 3/20 and 38% more sales on 7/10. This seems to suggest that cannabis retailers stand to significantly boost their sales numbers by combining sales promotions with discounted cannabis products.


William SumnerWilliam SumnerDecember 10, 2018
cresco2-1280x853.jpg

2min4660

Cresco Labs, Inc. (CSE: CL), a multi-state cannabis operator, today announced its financial results and operational highlights for the third quarter, which ended on September 30, 2018.

Revenue for the quarter increased to $12.2 million, representing a quarter-over-quarter increase of 51% and a year-over-year increase of 335%. Cresco’s net income nearly doubled from $2.0 million in the previous quarter to $3.9 million.

Gross profits, before gains from biological assets, increased to $5.4 million, compared to $3.5 million in the previous quarter. Adjusted EBITDA for the quarter rose from $2.1 million in the previous quarter to $5.9 million.

At the end of the quarter, the company had approximately $149.5 million in assets, which included $93.9 million in cash and cash equivalents. Cresco has a working capital position of roughly $105.3 million and long-term liabilities of about $2 million.

On December 17, 2018, at 5 PM Eastern Time, Cresco will hold a conference call to discuss its financial results for the quarter. A replay of the call will be made available on the company’s website following the call.

“As one of the early cannabis companies to establish a national geographic footprint with substantial population reach and production capacity, Cresco is leading the way in normalizing and professionalizing our industry,” said Charles Bachtell, Co-founder and CEO of Cresco Labs. “As a multi-state operator, we have repeatedly proven our ability to get access to markets, get operational, get product to markets, and get disproportionate market share.”

Following the closing of the quarter, Cresco entered the Massachusetts cannabis market with the acquisition of Hope Heal Health, Inc. Most recently the company went public on the Canadian Securities Exchange and began trading under the stock ticker “CSL” on December 3, 2018. Cresco is also in the process of receiving FINRA approval to trade on the OTC Market. The company also increased its liquidity by closing a $100 million Series F funding raise and another $85 million funded through institutional investors.



About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 4 hours

My week on Twitter 🎉: 18 Mentions, 89.8K Mention Reach, 18 Likes, 23 Retweets, 359K Retweet Reach. See yours with…

@GreenMarketRpt – 11 hours

⁦@CanopyGrowth⁩ $CGC speeds up US hemp move by Acquiring American Hemp Company AgriNext USA

Back to Top

You have Successfully Subscribed!